Quadrature Capital’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-43,185
Closed -$621K – 1727
2025
Q4
$621K Sell
43,185
-295,677
-87% -$5.12M 0.01% 640
2025
Q3
$6.41M Sell
338,862
-160,967
-32% -$2.65M 0.08% 177
2025
Q2
$10.7M Buy
499,829
+475,725
+1,974% +$7.07M 0.18% 114
2025
Q1
$316K Sell
24,104
-38,096
-61% -$566K 0.01% 714
2024
Q4
$835K Buy
62,200
+23,041
+59% +$371K 0.02% 470
2024
Q3
$831K Sell
39,159
-48,062
-55% -$866K 0.02% 392
2024
Q2
$1.38M Sell
87,221
-989
-1% -$18.2K 0.02% 389
2024
Q1
$1.31M Buy
+88,210
New +$1.21M 0.02% 407

Other funds holding OSCR

Quadrature Capital's OSCR Position: Q1 2026 in Review

Quadrature Capital sold out of Oscar Health (OSCR) in Q1 2026, closing a stake of 43,185 shares — an estimated $621K sold.

Quadrature Capital first reported a position in OSCR in Q1 2024 and held it in 8 quarters. The position peaked at $10.7M in Q2 2025. 333 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Quadrature Capital reported no remaining Oscar Health position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 43,185 Oscar Health shares in Q1 2026, an estimated $621K.
  • Quadrature Capital first reported a position in Oscar Health in Q1 2024 and held it in 8 quarters.
  • Quadrature Capital's Oscar Health position peaked at $10.7M in Q2 2025.
  • 333 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.